13F filer · CIK 1179392 ↗
Two Sigma
You are looking at Q1 2026. See the latest, Q2 2026 →
Reported value
$123.93B
+75% on the quarter before
Positions
4,546
1,074 new · 569 sold out
Top 10
9.4%
of the value
Est. gain
−$32.4M
on stocks held all quarter
Est. return
−0.1%
on those stocks since Q4 2025
Positions as of Mar 31, 2026, from Two Sigma's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 17% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2025. Striped tiles are options.
Largest buys
Since Q4 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$1.75BAdded · 0.3% → 1.6%+10,028,554 shares
- Apple~$1.28BAdded · 0.3% → 1.2%+5,052,600 shares
- Alphabet~$1.27BAdded · 0.0% → 1.0%+4,405,228 shares
- Amazon~$1.08BAdded · 0.4% → 1.1%+5,186,930 shares
- Tesla~$871.6MAdded · 0.4% → 0.9%+2,344,541 shares
- JPMorgan Chase~$857.1MAdded · 0.2% → 0.8%+2,913,874 shares
- Palantir~$711.8MAdded · 0.4% → 0.8%+4,866,142 shares
- Broadcom~$688.7MNew · 0.0% → 0.6%+2,225,253 shares
- Abbott Laboratories~$655.9MNew · 0.0% → 0.5%+6,388,828 shares
- Mastercard~$616.4MAdded · 0.4% → 0.7%+1,233,602 shares
Largest sells
Since Q4 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- LumentumPUT~$250.0MCut · 0.2% → 0.0%−355,700 underlying
- Amgen~$221.2MCut · 0.3% → 0.0%−628,708 shares
- Vaneck ETF Trust~$208.7MCut · 0.3% → 0.0%−544,450 shares
- Procter & Gamble~$205.0MCut · 0.3% → 0.0%−1,419,412 shares
- Astrazeneca Plc~$200.5MSold out · 0.3% → 0.0%−2,180,476 shares
- Select Sector SPDR Tr~$200.2MCut · 0.6% → 0.1%−1,506,521 shares
- Eaton~$198.4MCut · 0.3% → 0.0%−554,766 shares
- SPDR Series Trust~$181.6MCut · 0.3% → 0.0%−1,421,431 shares
- McDonald's~$177.0MCut · 0.3% → 0.0%−569,393 shares
- Select Sector SPDR Tr~$175.3MCut · 0.6% → 0.2%−1,608,366 shares
Holdings
As of Mar 31, 2026. Changes are in shares against Dec 31, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NvidiaCOM · shares +832% · price −6.5% | 1.6% | $1.96B | −$14.6M | ||||||||
| AppleCOM · shares +567% · price −6.6% | 1.2% | $1.51B | −$16.1M | ||||||||
| AmazonCOM · shares +452% · price −9.8% | 1.1% | $1.32B | −$25.9M | ||||||||
| AlphabetCAP STK CL A · shares +16,686% · price −8.1% | 1.0% | $1.27B | −$671,616 | ||||||||
| TeslaCOM · shares +413% · price −17.3% | 0.87% | $1.08B | −$44.3M | ||||||||
| JPMorgan ChaseCOM · shares +734% · price −8.7% | 0.79% | $973.9M | −$11.1M | ||||||||
| PalantirCL A · shares +311% · price −17.7% | 0.76% | $940.7M | −$49.2M | ||||||||
| CostcoCOM · shares +238% · price +15.5% | 0.70% | $871.7M | +$34.7M | ||||||||
| TJX CompaniesCOM · shares +212% · price +4.0% | 0.68% | $837.3M | +$10.2M | ||||||||
| MastercardCL A · shares +279% · price −12.5% | 0.68% | $837.0M | −$31.4M | ||||||||
| T-Mobile USCOM · shares +229% · price +3.4% | 0.66% | $817.3M | +$8.3M | ||||||||
| Lockheed MartinCOM · shares +178% · price +25.0% | 0.66% | $815.4M | +$58.5M | ||||||||
| Berkshire HathawayCL B NEW · shares +275% · price −4.7% | 0.63% | $777.1M | −$10.1M | ||||||||
| MicronCOM · shares +120% · price +18.4% | 0.62% | $773.8M | +$54.5M | ||||||||
| AdobeCOM · shares +322% · price −30.5% | 0.61% | $760.6M | −$79.3M | ||||||||
| Bristol Myers SquibbCOM · shares +147% · price +12.4% | 0.56% | $699.6M | +$31.3M | ||||||||
| Progressive CorporationCOM · shares +273% · price −12.9% | 0.56% | $699.4M | −$27.9M | ||||||||
| BroadcomCOM · shares New | 0.56% | $688.7M | — | ||||||||
| RobloxCL A · shares +300% · price −30.2% | 0.55% | $681.2M | −$73.6M | ||||||||
| Alnylam Pharmaceuticals IncCOM · shares +223% · price −16.8% | 0.53% | $659.3M | −$41.1M | ||||||||
| Abbott LaboratoriesCOM · shares New | 0.53% | $655.9M | — | ||||||||
| Intuitive SurgicalCOM NEW · shares +206% · price −18.6% | 0.52% | $647.8M | −$48.5M | ||||||||
| Western DigitalNOTE 3.000%11/1 · shares +43% · price +56.2% | 0.52% | $638.7M | — | ||||||||
| Regeneron PharmaceuticalsCOM · shares +189% · price +0.1% | 0.51% | $627.6M | +$216,487 | ||||||||
| Morgan StanleyCOM NEW · shares +235% · price −7.3% | 0.50% | $615.4M | −$14.5M | ||||||||
| Total · 4,546 positions | 100% | $123.93B | −$32.4M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2025 to Q1 2026: 2,941 stocks held throughout, down $32.4M (−0.1%).
- Sandisk+$284.6M+168%
- Atlassian5:1 split+$163.8M+110%
- Moderna+$156.5M+72%
- Unity5:1 split+$103.7M+148%
- Bloom Energy+$94.2M+56%
- Sea−$76.6M−35%
- ServiceNow−$78.5M−32%
- Adobe−$79.3M−31%
- Boston Scientific−$80.6M−34%
- The Trade Desk−$92.3M−40%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 22 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $138.12B+11% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $123.93B+75% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $70.90B+6% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $67.17B+19% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $56.47B+21% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $46.79B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $45.85B+0% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $45.63B+4% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $43.90B+3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $42.61B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $43.54B+17% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $37.17B−7% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $39.87B+14% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $34.99B+10% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $31.85B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $29.43B−3% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $30.30B−11% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $33.88B−28% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $46.81B+5% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $44.75B+1% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $44.08B+15% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $38.44B+10% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $34.85B+24% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $28.17B+40% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $20.19B+64% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $12.28B−63% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $33.24B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $29.72B−1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $29.90B−3% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $30.85B+21% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $25.54B−30% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $36.69B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $33.54B+12% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $30.04B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $30.72B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $28.21B+2% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $27.64B−7% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $29.70B+14% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $26.08B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $27.59B+18% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.29B+11% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $20.99B | SEC ↗ |